Method of treating tumor growth and metastasis by using trifunctional antibodies to reduce the risk for graft-versus-host disease in allogeneic antitumor cell therapy

Author： Lum Lawrence G   Yang Wen  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.17, Iss.4, 2007-04, pp. : 459-464

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal Antibodies to Treat Graft-Versus-Host Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 6, 2011-06 ,pp. : 473-479

Bentham Science Publishers

Access to resources Recommend Favorite

Oral beclomethasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease following allogeneic hematopoietic cell transplantation

By McDonald George B  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 10, 2007-10 ,pp. : 1709-1724

Informa Healthcare

Access to resources Recommend Favorite

Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft‐versus‐host disease and survival outcome

By  

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 276-284

John Wiley & Sons Inc

Access to resources Recommend Favorite

Chronic Graft-Versus-Host Disease

By  

Current Pharmaceutical Design, Vol. 14, Iss. 20, 2008-07 ,pp. : 1974-1986

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Cytokine Therapy for the Treatment of Graft-Versus-Host Disease

By  

Current Pharmaceutical Design, Vol. 10, Iss. 11, 2004-04 ,pp. : 1195-1205

Bentham Science Publishers

Access to resources Recommend Favorite